Incorporation of exogenous ganglioside GM1 into neuroblastoma membranes: inhibition by calcium ion and dependence upon membrane protein.
Since exogenous gangliosides are known to promote neuritogenesis, the incorporation of exogenous GM1 into neuroblastoma membranes was examined. Neuro-2A cells, synchronized in the G1/G0 phase, were suspended in HEPES buffered saline containing 10(-4) M [3H]GM1, and membrane incorporation was measured as radioactivity remaining with the cell pellet following incubation with serum-containing medium and trypsin. Calcium ion (0.01 to 10 mM) reduced incorporation of exogenous GM1, due to its interaction with GM1 micelles in solution. When cells were treated with proteases prior to incubation with GM1, the inhibitory effect of Ca2+ was lost and total incorporation into membranes was lowered by approximately one order of magnitude. Pretreatment of cells with 0.05% trypsin resulted in an inhibition of GM1 incorporation within 5 minutes. When trypsinized cells were resuspended in complete growth medium, the cells recovered the ability to incorporate GM1 with time, and this paralleled labeling of cellular protein with [3H]leucine. The role of membrane protein in the incorporation of exogenous GM1 could not be explained by the lytic release of cytosolic transfer proteins nor the artifactual coating of the cell surface by serum proteins. These results suggest that the incorporation of exogenous gangliosides into cellular membrane lipid bilayers cannot be fully explained by considerations of lipophilicity alone, and leads us to propose that initial recognition by membrane protein(s) is necessary.
Leskawa
K C
KC
Department of Anatomical Sciences and Neurobiology, School of Medicine, University of Louisville, KY 40292.
Erwin
R E
RE
Leon
A
A
Toffano
G
G
Hogan
E L
EL
D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D002462:Cell Membrane / Q000378:metabolism; D005677:G(M1) Ganglioside / Q000378:metabolism*; D006821:Hyaluronoglucosaminidase / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007158:Immunologic Techniques; D066298:In Vitro Techniques; D008563:Membrane Lipids / Q000378:metabolism*; D008565:Membrane Proteins / Q000502:physiology*; D051379:Mice; D009447:Neuroblastoma / Q000378:metabolism*; D010447:Peptide Hydrolases / Q000494:pharmacology; D012995:Solubility; D014407:Tumor Cells, Cultured
D008563:Membrane Lipids; D008565:Membrane Proteins; D005677:G(M1) Ganglioside; D006821:Hyaluronoglucosaminidase; D010447:Peptide Hydrolases; D002118:Calcium